Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
In the previous paper of ours we compared, prior to start any treatment, a number of immunological parameters in 24 chronic myeloid leukemia patients with the same number of healthy subjects matched by age and sex. We found significant differences in the levels of immunoglobulins, the C4 component o...
Saved in:
Main Authors: | Zuzana Humlová, Hana Klamová, Ivana Janatková, Karin Malícková, Petra Králíková, Ivan Šterzl, Zdeněk Roth, Eva Hamšíková, Vladimír Vonka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2010/137320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
by: Petra Belohlavkova, et al.
Published: (2024-09-01) -
Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract
by: Ryan M. Kahn, et al.
Published: (2019-01-01) -
Acute Myeloid Leukemia Presenting with Pulmonary Tuberculosis
by: Merlin Thomas, et al.
Published: (2014-01-01) -
Concurrent Central Diabetes Insipidus and Acute Myeloid Leukemia
by: Stephanie L. Pritzl, et al.
Published: (2021-01-01) -
The origins of the definition of complete remission in acute myeloid leukemia
by: Mark R. Litzow
Published: (2025-02-01)